Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

drugalertMay 3 2016

An incorrect blister strip has been found in a pack of parallel imported Crestor 5mg tablets prompting a Class 4 (caution in use) drug alert.

The medicines regulator, the MHRA, said that one pack of PI Crestor 5mg tablets, batch number S347A/3153 (originator name Provisacor), “has been found to contain a rogue blister of 20mg tablets (batch S348A). The rogue blister was over labelled as 5mg tablets, batch S347A/3153. The second blister in the pack was correct (5mg).”

It has advised that, as a consequence, pharmacy stocks may still hold:

  • a further 5mg carton containing a rogue blister of 20mg tablets; or
  • one 20mg carton, over-labelled as 5mg S347A/3153, containing two blisters of 5mg tablets.

“Pharmacists are asked to check any remaining stock of Crestor 5mg tablets batch S347A/3153 to ensure that the carton and both blisters are correct,” said the MHRA.

If a problem is found, the pharmacy should contact AAH Pharmaceuticals’ Regulatory Department by email This email address is being protected from spambots. You need JavaScript enabled to view it. or telephone 02476 532359 to arrange uplift and credit.


MHRA drug alert

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...